Learn how you can TAP into expert advice via the FDA’s Total Product Lifecycle Advisory Program through early, holistic support—regulatory, clinical, payer, and patient insight—for breakthrough-designated medical devices. With tailored FDA engagement and stakeholder input, TAP is a beacon to accelerate device development, approval, and patient access.

Speakers:

• Paul Grand, MedTech Innovator (Moderator)
• Scott Schorer, FDA Contractor (CDHR, TAP)
• Douglas Kelly, MD, Deputy Center Director for Science, Chief Scientist, Center for Devices and Radiological Health at FDA